One of the primary impacts of HB 305 is the requirement for rigorous timelines for adverse decision procedures and internal grievance processes, which will demand that denial notifications be issued swiftly and with clear explanations. The bill increases penalties for violations by private review agents that hinder timely access to care, thus holding these entities accountable. Moreover, this legislative shift aims to address the long-standing concerns regarding the excessive administrative burdens placed on healthcare providers, which can result in delays in delivering necessary medical services to patients, especially in urgent cases.
Summary
House Bill 305 proposes significant revisions to health insurance utilization review processes, focusing specifically on the preauthorization requirements imposed on both providers and patients. The bill mandates that all payors implement standardized and automated systems to streamline preauthorization requests, ultimately aimed at improving access to healthcare services. By establishing a unified online system for tracking authorizations and providing real-time decisions, the legislation seeks to enhance communication and coordination between healthcare providers and payors, making the healthcare delivery system more efficient.
Contention
There are notable points of contention surrounding HB 305, particularly regarding the balance of power between insurance providers and healthcare practitioners. Critics may argue that, while the intent is to streamline operations and enhance patient access, the feasibility of widespread implementation of these automated systems might encounter resistance from payors who could be challenged by the costs and administrative changes required. Furthermore, the bill raises questions about how effectively it will ensure that patients with complex medical needs will not be adversely affected by automated decision-making systems that may lack the flexibility of human oversight.
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Maryland Medical Assistance Program and Health Insurance - Coverage and Utilization Review - Drugs Reviewed by the Prescription Drug Affordability Board
Relating to disclosures of preauthorization requirements and explanations of benefits for medical and health care services and supplies covered by health maintenance organizations and preferred provider benefit plans; imposing administrative penalties.